Tesamorelin (10mg)

$100

A targeted growth hormone secretagogue proven to reduce stubborn visceral belly fat. Clinical trials demonstrate 15-18% reductions in visceral adipose tissue over 26 weeks, along with significant improvements in body composition without affecting subcutaneous fat.

Description

A targeted growth hormone secretagogue proven to reduce stubborn visceral belly fat. Clinical trials demonstrate 15-18% reductions in visceral adipose tissue over 26 weeks, along with significant improvements in body composition without affecting subcutaneous fat.

Reviews

There are no reviews yet.

Be the first to review “Tesamorelin (10mg)”

Your email address will not be published. Required fields are marked *